首页> 外文期刊>Bone marrow transplantation >Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors
【24h】

Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors

机译:急性胃肠杆菌GVHD与同种异体造血干细胞移植受体和供体基线肠道微生物的关联

获取原文
获取原文并翻译 | 示例
           

摘要

Growing evidence suggests that host-microbiota interactions influence GvHD risk following allogeneic hematopoietic stem cell transplant. However, little is known about the influence of the transplant recipient's pre-conditioning microbiota nor the influence of the transplant donor's microbiota. Our study examines associations between acute gastrointestinal GvHD (agGvHD) and 16S rRNA fecal bacterial profiles in a prospective cohort of A/=57 recipients before preparative conditioning, as well as N = 22 of their paired HLA-matched sibling donors. On average, recipients had lower fecal bacterial diversity (P=0.0002) and different phylogenetic membership (UniFrac P=0.001) than the healthy transplant donors. Recipients with lower phylogenetic diversity had higher overall mortality rates (hazard ratio = 0.37, P = 0.008), but no statistically significant difference in agGvHD risk. In contrast, high bacterial donor diversity was associated with decreased agGvHD risk (odds ratio = 0.12, P = 0.038). Further investigation is warranted as to whether selection of hematopoietic stem cell transplant donors with high gut microbiota diversity and/or other specific compositional attributes may reduce agGvHD incidence, and by what mechanisms. The success of allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains limited by GvHD. Even among transplants sourced from 'gold standard' donors (HLA-matched siblings), acute GvHD occurs in 35-45% of recipients,1'2 highlighting the need to continue investigating GvHD etiology and new strategies for prophylaxis. The 16S rRNA sequencing has enabled a dramatic re-evaluation of the relationships between GvHD and the intestinal bacteria.3"5 The pre-transplant microbiota of recipients has been reported to approximate the diverse microbiota compositions of healthy adults before transplant, but becomes dramatically altered following transplant procedures.
机译:日益增长的证据表明,在同种异体造血干细胞移植后,Host-Microbiota相互作用影响GVHD风险。然而,关于移植受体的预调节微生物群或移植供体微生物的影响的影响很少。我们的研究在制备调节前在预期队列的前瞻性队列中的急性胃肠GVHD(AGGVHD)和16S rRNA粪便细菌细胞谱之间的关联检测急性胃肠道GVHD(AGGVHD)和16S rRNA粪便细菌谱之间的关联,以及其成对的HLA匹配的兄弟提供者的N = 22。平均而言,受者的粪便细菌多样性较低(P = 0.0002)和不同的系统发育成员(UNIFRAC P = 0.001),而不是健康的移植施主。具有较低的系统发育多样性的受体具有较高的总体死亡率(危险比= 0.37,P = 0.008),但AGGVHD风险没有统计学意义差异。相反,高细菌供体多样性与AgGVHD风险降低有关(差距= 0.12,P = 0.038)。有必要进一步调查,以便选择具有高压肠道微生物群多样性和/或其他特异性组成属性的造血干细胞移植施主可以降低AgGVHD发病率,以及通过什么机制。同种异体造血干细胞移植(Allo-HSCT)的成功仍然受到GVHD的限制。甚至在从“黄金标准”捐赠者(HLA匹配的兄弟姐妹)中的移植中,急性GVHD在35-45%的受者中发生,1'2突出了继续研究GVHD病因和预防性的新策略。 16S rRNA测序使GVHD和肠道细菌之间的关系的戏剧性重新评估表明,据报道,接受者的移植前微生物群是在移植前近似健康成年人的多种微生物群组成,但变得显着改变进行移植程序后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号